Shire, NPS Pharma to merge in $5.2 billion deal

Chris Ratcliffe | Bloomberg | Getty Images

Shire said it will acquire NPS Pharmaceuticals in an all-stock transaction for about $5.2 billion, the companies said in a joint statement on Sunday.

Shire will pay $46.00 per NPS share, representing a premium of about 7.2 percent over NPS' Friday close.

Dublin-based Shire, whose proposed sale to AbbVie Inc fell apart in October, expects the deal to add to its adjusted earnings from 2016 onward.